Boehringer Ingelheim Pharmaceuticals, Inc. Company Profile
✉ Email this page to a colleague
Biologic Drugs for Boehringer Ingelheim Pharmaceuticals, Inc.
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND | idarucizumab | Injection | 761025 | 10,501,773 | 2035-07-30 | Patent claims search |
| Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND | idarucizumab | Injection | 761025 | 10,590,182 | 2036-02-23 | Patent claims search |
| Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND | idarucizumab | Injection | 761025 | 10,703,800 | 2037-04-26 | Patent claims search |
| Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND | idarucizumab | Injection | 761025 | 10,954,549 | 2039-11-05 | Patent claims search |
| Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND | idarucizumab | Injection | 761025 | 8,486,398 | 2031-01-20 | DrugPatentWatch analysis and company disclosures |
| Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND | idarucizumab | Injection | 761025 | 9,034,822 | 2033-06-13 | DrugPatentWatch analysis and company disclosures |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
Similar Applicant Names
This search can help find similar names.
